{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:06:39Z","timestamp":1785179199374,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18590-x","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T11:59:59Z","timestamp":1759751999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of inflammatory and nutritional markers obtained at the time of diagnosis in patients diagnosed with renal cell carcinoma"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3093-0738","authenticated-orcid":false,"given":"Hatice Basaran","family":"Goksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1321-3465","authenticated-orcid":false,"given":"Alaettin","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"3","key":"18590_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","volume":"67","author":"A Znaor","year":"2015","unstructured":"Znaor, A., Lortet-Tieulent, J., Laversanne, M., Jemal, A. & Bray, F. International variations and trends in renal cell carcinoma incidence and mortality. Eur. Urol. 67 (3), 519\u2013530. https:\/\/doi.org\/10.1016\/j.eururo.2014.10.002 (2015).","journal-title":"Eur. Urol."},{"issue":"5","key":"18590_CR2","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.eururo.2012.02.039","volume":"61","author":"S MacLennan","year":"2012","unstructured":"MacLennan, S. et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur. Urol. 61 (5), 972\u2013993. https:\/\/doi.org\/10.1016\/j.eururo.2012.02.039 (2012).","journal-title":"Eur. Urol."},{"issue":"8","key":"18590_CR3","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00345-016-1773-y","volume":"34","author":"S Dabestani","year":"2016","unstructured":"Dabestani, S. et al. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J. Urol. 34 (8), 1081\u20131086. https:\/\/doi.org\/10.1007\/s00345-016-1773-y (2016).","journal-title":"World J. Urol."},{"issue":"6","key":"18590_CR4","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/S0022-5347(05)64153-5","volume":"168","author":"I Frank","year":"2002","unstructured":"Frank, I. et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J. Urol. 168 (6), 2395\u20132400. https:\/\/doi.org\/10.1016\/S0022-5347(05)64153-5 (2002).","journal-title":"J. Urol."},{"issue":"34","key":"18590_CR5","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","volume":"27","author":"DY Heng","year":"2009","unstructured":"Heng, D. Y. et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J. Clin. Oncol. 27 (34), 5794\u20135799. https:\/\/doi.org\/10.1200\/JCO.2008.21.4809 (2009).","journal-title":"J. Clin. Oncol."},{"key":"18590_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijsu.2020.05.019","volume":"79","author":"N Zhang","year":"2020","unstructured":"Zhang, N. et al. Prognostic role of pretreatment lactate dehydrogenase in patients with metastatic renal cell carcinoma: A systematic review and meta-analysis. Int. J. Surg. 79, 66\u201373. https:\/\/doi.org\/10.1016\/j.ijsu.2020.05.019 (2020).","journal-title":"Int. J. Surg."},{"issue":"1","key":"18590_CR7","doi-asserted-by":"publisher","first-page":"50e1","DOI":"10.1016\/j.urolonc.2013.07.016","volume":"32","author":"Q Hu","year":"2014","unstructured":"Hu, Q. et al. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis. Urol. Oncol. 32 (1), 50e1\u201350e8. https:\/\/doi.org\/10.1016\/j.urolonc.2013.07.016 (2014).","journal-title":"Urol. Oncol."},{"issue":"8","key":"18590_CR8","doi-asserted-by":"publisher","first-page":"e0271821","DOI":"10.1371\/journal.pone.0271821","volume":"17","author":"SR Shim","year":"2022","unstructured":"Shim, S. R., Kim, S. I., Kim, S. J. & Cho, D. S. Prognostic nutritional index as a prognostic factor for renal cell carcinoma: A systematic review and meta-analysis. PLoS One. 17 (8), e0271821. https:\/\/doi.org\/10.1371\/journal.pone.0271821 (2022).","journal-title":"PLoS One"},{"issue":"1","key":"18590_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12894-020-00665-8","volume":"20","author":"Y Shao","year":"2020","unstructured":"Shao, Y. et al. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis. BMC Urol. 20 (1), 90. https:\/\/doi.org\/10.1186\/s12894-020-00665-8 (2020).","journal-title":"BMC Urol."},{"issue":"2","key":"18590_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/03936155221081536","volume":"37","author":"X Zhou","year":"2022","unstructured":"Zhou, X. & Luo, G. A meta-analysis of the platelet-lymphocyte ratio: A notable prognostic factor in renal cell carcinoma. Int. J. Biol. Markers. 37 (2), 123\u2013133. https:\/\/doi.org\/10.1177\/03936155221081536 (2022).","journal-title":"Int. J. Biol. Markers"},{"issue":"5","key":"18590_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00345-016-1940-1","volume":"35","author":"SR Shim","year":"2017","unstructured":"Shim, S. R., Kim, S. J., Kim, S. I. & Cho, D. S. Prognostic value of the Glasgow prognostic score in renal cell carcinoma: a meta-analysis. World J. Urol. 35 (5), 771\u2013780. https:\/\/doi.org\/10.1007\/s00345-016-1940-1 (2017).","journal-title":"World J. Urol."},{"issue":"10","key":"18590_CR12","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/cncr.33420","volume":"127","author":"JM Lebenthal","year":"2021","unstructured":"Lebenthal, J. M. et al. Prognostic value of the memorial sloan kettering prognostic score in metastatic pancreatic adenocarcinoma. Cancer 127 (10), 1568\u20131575. https:\/\/doi.org\/10.1002\/cncr.33420 (2021).","journal-title":"Cancer"},{"issue":"19","key":"18590_CR13","doi-asserted-by":"publisher","first-page":"19656","DOI":"10.1002\/cam4.6608","volume":"12","author":"M Wan","year":"2023","unstructured":"Wan, M. et al. The memorial sloan kettering prognostic score: correlation with survival in patients with advanced gastric cancer. Cancer Med. 12 (19), 19656\u201319666. https:\/\/doi.org\/10.1002\/cam4.6608 (2023).","journal-title":"Cancer Med."},{"key":"18590_CR14","doi-asserted-by":"publisher","first-page":"1219929","DOI":"10.3389\/fimmu.2023.1219929","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Prognostic nutritional index as a prognostic biomarker for Gastrointestinal cancer patients treated with immune checkpoint inhibitors. Front. Immunol. 14, 1219929. https:\/\/doi.org\/10.3389\/fimmu.2023.1219929 (2023).","journal-title":"Front. Immunol."},{"issue":"9","key":"18590_CR15","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.21037\/jtd.2018.08.51","volume":"10","author":"D Li","year":"2018","unstructured":"Li, D., Yuan, X., Liu, J., Li, C. & Li, W. Prognostic value of prognostic nutritional index in lung cancer: a meta-analysis. J. Thorac. Dis. 10 (9), 5298\u20135307. https:\/\/doi.org\/10.21037\/jtd.2018.08.51 (2018).","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"18590_CR16","doi-asserted-by":"publisher","first-page":"17117","DOI":"10.1038\/s41598-021-96598-9","volume":"11","author":"CW Luan","year":"2021","unstructured":"Luan, C. W. et al. Pretreatment prognostic nutritional index as a prognostic marker in head and neck cancer: a systematic review and meta-analysis. Sci. Rep. 11 (1), 17117. https:\/\/doi.org\/10.1038\/s41598-021-96598-9 (2021).","journal-title":"Sci. Rep."},{"key":"18590_CR17","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3389\/fonc.2020.01541","volume":"10","author":"T Tong","year":"2020","unstructured":"Tong, T., Guan, Y., Xiong, H., Wang, L. & Pang, J. A Meta-Analysis of Glasgow prognostic score and modified Glasgow prognostic score as biomarkers for predicting survival outcome in renal cell carcinoma. Front. Oncol. 10, 1541. https:\/\/doi.org\/10.3389\/fonc.2020.01541 (2020).","journal-title":"Front. Oncol."},{"issue":"1","key":"18590_CR18","doi-asserted-by":"publisher","first-page":"25045","DOI":"10.1038\/s41598-024-76519-2","volume":"14","author":"W Ma","year":"2024","unstructured":"Ma, W. et al. Predicting the prognosis of patients with renal cell carcinoma based on the systemic immune inflammation index and prognostic nutritional index. Sci. Rep. 14 (1), 25045. https:\/\/doi.org\/10.1038\/s41598-024-76519-2 (2024).","journal-title":"Sci. Rep."},{"issue":"2","key":"18590_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/biomedicines11020533","volume":"11","author":"T Makino","year":"2023","unstructured":"Makino, T. et al. Comparison of the prognostic value of inflammatory and nutritional indices in nonmetastatic renal cell carcinoma. Biomedicines 11 (2), 533. https:\/\/doi.org\/10.3390\/biomedicines11020533 (2023).","journal-title":"Biomedicines"},{"issue":"1","key":"18590_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12893-023-02001-x","volume":"23","author":"W Ren","year":"2023","unstructured":"Ren, W. et al. Clinical significance of prognostic nutritional index (PNI)-monocyte-to-lymphocyte ratio (MLR)-platelet (PLT) score on postoperative outcomes in non-metastatic clear cell renal cell carcinoma. BMC Surg. 23 (1), 117. https:\/\/doi.org\/10.1186\/s12893-023-02001-x (2023).","journal-title":"BMC Surg."},{"issue":"12","key":"18590_CR21","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/cncr.33462","volume":"127","author":"MI Higgins","year":"2021","unstructured":"Higgins, M. I. et al. Sarcopenia and modified Glasgow prognostic score predict postsurgical outcomes in localized renal cell carcinoma. Cancer 127 (12), 1974\u20131983. https:\/\/doi.org\/10.1002\/cncr.33462 (2021).","journal-title":"Cancer"},{"issue":"8","key":"18590_CR22","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jamaoncol.2023.1822","volume":"9","author":"J Saal","year":"2023","unstructured":"Saal, J. et al. Integrating On-Treatment modified Glasgow prognostic score and imaging to predict response and outcomes in metastatic renal cell carcinoma. JAMA Oncol. 9 (8), 1048\u20131055. https:\/\/doi.org\/10.1001\/jamaoncol.2023.1822 (2023).","journal-title":"JAMA Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18590-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18590-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:07:34Z","timestamp":1760141254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18590-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18590"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18590-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Research Ethics Committee (EC) of Kayseri City Education amd Research Hospital (local EC Date: 08\/10\/2024, Decision no: 215) in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"34771"}}